How to Find and Report Your Child’s Vaccine Records
Don't let lost paperwork lead to school suspension. Follow our "Record Rescue" checklist and learn about the CANImmunize app today.
Is an AI Redesign the Answer to Canada’s Healthcare Wait Times?
Discover how a system-wide AI redesign could revolutionize Canadian healthcare productivity, diagnosis, and drug discovery according to the Fraser Institute.
New CPR Guidelines for Canada: Why “Rescue Breaths” are Back for Kids
Heart & Stroke’s updated guidelines emphasize that children need rescue breaths during CPR, as their cardiac arrests are typically oxygen-related.
Doctors Warn Canadians are “5x More Likely” to Experience Harm from AI Health Advice
A new report released today by the Canadian Medical Association (CMA) has revealed a dangerous new reality: Canadians…
What’s Driving 105,000 Canadians A Year To Seek Care Abroad?
105,529 Canadians sought care abroad last year. From urology to eye surgery, we break down the procedures driving the exodus and how to stay safe.
6 Million Canadians Living with Heart Disease: New 2026 Report
Heart & Stroke report reveals 90% of Canadians have at least one risk factor for heart disease. Learn about the new data on hypertension, diabetes, and vaping.
Your Plants Impact Your Health and Your Pet’s Health
Struggling with dry air and winter blues? Staff your home with the right plants. A room-by-room guide to health, safety, and pet-friendly greenery.
The $37 Billion Blind Spot: Why Canada Needs to Close the Women’s Health Gap
Canadian women spend 24% more time in poor health than men. Discover why this $37B gap exists and how to advocate for the care you deserve.
Kidney Breakthrough: Health Canada Authorizes First-of-its-Kind Treatment for Lupus Nephritis
Health Canada authorizes Gazyva for lupus nephritis. Discover how this twice-yearly treatment improves kidney response and prevents failure.
Health Canada Authorizes Nemluvio® for Eczema and Prurigo Nodularis
Health Canada authorized Nemluvio® (nemolizumab), a first-in-class biologic for eczema and prurigo nodularis. Learn about costs and coverage.
Health Canada Authorizes First GLP-1 Pill to Reduce Heart Attack and Stroke Risk
Health Canada authorizes RYBELSUS® as the first oral GLP-1 to reduce heart attack and stroke risk in adults with type 2 diabetes.
There’s a Reason Your Voice May Not Be As Clear as it Can Be
From dry winters to loud parties, your voice takes a beating. Learn how to protect your "vocal instrument" with these expert tips and SAC guidelines.